Induction chemotherapy before surgery for early-stage lung cancer: A novel approach

Journal of Thoracic and Cardiovascular Surgery

Volumn 119, Issue 3, 2000, Pages 429-439

  Pisters, K M W ^a   Ginsberg, R J ^a   Giroux, D J ^a   Putnam, J B ^a   Kris, M G ^a   Johnson, D H ^a   Roberts, J R ^a   Mault, J ^a   Crowley, J J ^a   Bunn, P A ^a  

^a Bimodality Lung Oncology Team (BLOT)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; FEMALE; HUMAN; LUNG CANCER; MALE; MORBIDITY; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034020907     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(00)70120-6     Document Type: Article

References (25)

1. SH Landis T Murray S Bolden PA. Wingo Cancer Statistics, 1999 CA Cancer J Clin 49 1999 8 31
2. CF. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
3. RD Dillman SL Seagren KF Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer N Engl J Med 323 1990 940 945
4. WT Sause C Scott S Taylor Radiation therapy oncology group (RTOG) and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer J Natl Cancer Inst 87 1995 198 205
5. JA Roth F Fossella R Komaki A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non–small cell lung cancer J Natl Cancer Inst 86 1994 673 680
6. R Rosell J Gomez-Codina C Camps A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non–small cell lung cancer N Engl J Med 330 1994 153 158
7. CJ Langer JC Leighton RL Comis Paclitaxel by 24-hour or 1-hour infusion in combination with carboplatin in advanced non–small cell lung cancer: the Fox Chase Cancer Center experience Semin Oncol 22 Suppl 9 1995 18 29
8. CP Belani D Hiponia C Engstrom Phase I study of paclitaxel and carboplatin in advanced and metastatic non–small cell lung cancer [abstract] Proc Am Soc Clin Oncol 14 1995 A381
9. DH Johnson DM Paul KR Hande Paclitaxel (taxol) plus carboplatin for advanced lung cancer: preliminary results of a Vanderbilt University phase II trial-LUN-46 Semin Oncol 22 Suppl 9 1995 30 33
10. FM Muggia D Vafai R Natale Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials Semin Oncol 22 Suppl 9 1995 63 66
11. EK Rowinsky WA Flood SE Sartorius Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non–small cell lung cancer Semin Oncol 22 Suppl 9 1995 48 54
12. PA Bunn K. Kelly A phase I study of carboplatin and paclitaxel (taxol) in non–small cell lung cancer: a University of Colorado Cancer Center study Semin Oncol 22 Suppl 9 1995 2 6
13. G Giaccone M Huizing P Postmus Dose-finding and sequencing study of paclitaxel and carboplatin in non–small cell lung cancer Semin Oncol 22 Suppl 9 1995 78 82
14. Non–Small Cell Lung Cancer Collaborative Group Chemotherapy in non–small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized trials BMJ 311 1995 899 909
15. PORT Meta-Analysis Trialists Group Postoperative radiotherapy in non–small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials Lancet 352 1998 257 263
16. RL Burkes RJ Ginsberg FA Shepherd Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non–small cell lung cancer: results of the Toronto phase II trial J Clin Oncol 10 1992 580 586
17. S Darwish V Minotti L Crino Neoadjuvant cisplatin and etoposide for stage IIIA (clinical N2) non–small cell lung cancer Am J Clin Oncol 17 1994 64 67
18. N Martini MG Kris BJ Flehinger Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Memorial Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1374
19. EE Vokes JD Bitran PC Hoffman Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non–small cell lung cancer Chest 96 1989 110 113
20. KMW Pisters MG Kris RJ Gralla Pathologic complete response in advanced non–small cell lung cancer following preoperative chemotherapy: implications for the design of future non–small cell lung cancer combined modality trials J Clin Oncol 11 1993 1757 1762
21. A Depierre B Milleron D Moro Phase III trial of neo-adjuvant chemotherapy in resectable stage I (except T1 N0), II, and IIIa non–small cell lung cancer: the French experience [abstract] Proc Am Soc Clin Oncol 18 1999 465a
22. CP Belani RB Natale JS Lee Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non–small cell lung cancer [abstract] Proc Am Soc Clin Oncol 17 1998 455a
23. R Feld L Rubinstein PR Thomas the Lung Cancer Study Group Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non–small cell lung cancer J Natl Cancer Inst 85 1993 299 306
24. The Lung Cancer Study Group Final analysis Chest 106 1994 279S 410S
25. KMW Pisters MG Kris RJ Gralla Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non–small cell lung cancer J Surg Oncol 56 1994 236 241